Replimune to resubmit melanoma drug application after FDA feedback
Filed May 29, 2026 · Period ending May 29, 2026 · ~1 min read
2 material changes detected in this filing.
Create a free account to read the full summary — it takes 30 seconds.
Partner
Trade REPL commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Generated by AI · Jun 1, 2026 4:35 AM